Castle Biosciences (CSTL) Change in Inventory (2018 - 2026)

Castle Biosciences has disclosed Change in Inventory across 9 years of filings, most recently posting $207000.0 for Q1 2026.

• Change in Inventory for Q1 2026 came in at $207000.0, up 116.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.6 million (up 556.66% YoY), and the FY2025 annual result was $2.1 million, up 1009.84% from the prior year.
• Change in Inventory came in at $207000.0 for Q1 2026 at Castle Biosciences, down from $1.6 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $2.2 million in Q4 2023 to a low of -$1.4 million in Q3 2024.
• The 5-year median for Change in Inventory is $368000.0 (2024), against an average of $481411.8.
• Across the five-year window, Change in Inventory jumped 1120.79% in 2023 and plunged 333.0% in 2025, its largest moves.
• Castle Biosciences' Change in Inventory stood at $178000.0 in 2022, then surged by 1120.79% to $2.2 million in 2023, then slipped by 28.07% to $1.6 million in 2024, then increased by 2.62% to $1.6 million in 2025, then sank by 87.09% to $207000.0 in 2026.
• The last three Change in Inventory figures came in at $207000.0 (Q1 2026), $1.6 million (Q4 2025), and $307000.0 (Q3 2025), per Business Quant data.